Splenic marginal zone lymphoma in Sweden 2000–2020: Increasing rituximab use and better survival in the elderly

The treatment of splenic marginal zone lymphoma is debated: splenectomy (the old standard‐of‐care) is better than chemotherapy but maybe not better than rituximab‐containing treatment. We examined all 358 patients diagnosed with splenic marginal zone lymphoma in Sweden 2000–2020. The median overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Junlén, Henna‐Riikka, Sonnevi, Kristina, Lindén, Ola, Hellström, Mats, Scivetti, Mariana Villegas, Olsson, Mikael, Tufvesson, Ida, Johansson, Ann‐Sofie, Wahlin, Björn Engelbrekt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Haematologic Malignancy ‐ Lymphoid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435707/
https://www.ncbi.nlm.nih.gov/pubmed/37601869
http://dx.doi.org/10.1002/jha2.696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435707/
https://www.ncbi.nlm.nih.gov/pubmed/37601869
http://dx.doi.org/10.1002/jha2.696

Ejemplares similares